CHRONIC GRAFT VERSUS HOST DISEASE

This adverse event was reported 1939 times

These drugs are most commonly taken by patients reporting CHRONIC GRAFT VERSUS HOST DISEASE:

# Drug Count
0 METHOTREXATE SODIUM 717
1 METHOTREXATE 700
2 CYCLOPHOSPHAMIDE 565
3 TACROLIMUS 534
4 CYCLOSPORINE 506
5 FLUDARABINE PHOSPHATE 444
6 MYCOPHENOLATE MOFETIL 431
7 BUSULFAN 419
8 TACROLIMUS CAPSULES 352
9 MELPHALAN HYDROCHLORIDE 222
See all common drugs associated with CHRONIC GRAFT VERSUS HOST DISEASE

CHRONIC GRAFT VERSUS HOST DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICLOFENAC SODIUM TOPICAL SOLUTION 1 0.1429
1 BUSULFAN 419 0.0563
2 METHOXSALEN 5 0.0365
3 THIOTEPA 101 0.0352
4 FLUDARABINE PHOSPHATE 444 0.0292
5 ANTI-THYMOCYTE GLOBULIN (RABBIT) 125 0.0292
6 DEFIBROTIDE SODIUM 12 0.0222
7 PENTAMIDINE ISETHIONATE 14 0.0212
8 MELPHALAN HYDROCHLORIDE 222 0.0164
9 DECITABINE 20 0.0132
See all drugs enriched for association with CHRONIC GRAFT VERSUS HOST DISEASE

These drug classes are most commonly taken by patients reporting CHRONIC GRAFT VERSUS HOST DISEASE:

# Drug class Count
0 Purine Antimetabolite [EPC] 19
1 Insulin Analog [EPC] 3
2 Stimulant Laxative [EPC] 1
See all common drug classes associated with CHRONIC GRAFT VERSUS HOST DISEASE

CHRONIC GRAFT VERSUS HOST DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 19 0.0005
1 Stimulant Laxative [EPC] 1 0.0001
2 Insulin Analog [EPC] 3 0.0000
See all drug classes enriched for association with CHRONIC GRAFT VERSUS HOST DISEASE